Alongside MPN-specific immunity, protective T cell responses directed towards PD-L1 and ARG1 were revealed in about two thirds of MPN cases, showing higher frequencies of these antitumor T lymphocytes in patients with non-advanced disease, compared to weaker magnitudes observed in advanced MPN patients [133,134]. Here, ARG1 is linked to myeloproliferative disorder.